Aims: This review aimed at investigating the effect of membrane exposure on guided bone regeneration (GBR) outcomes at peri-implant sites and edentulous ridges.
site for future implant placement, ideal treatment outcomes demand sufficient horizontal and vertical ridge dimensions. To prevent further bone remodeling after implant placement, Spray, Black, Morris, and Ochi (2000) proposed a need for 1.8 mm of bone thickness at the buccal aspect of the implant and 0.5 mm at the palatal aspect to ensure long-term success. In addition, Tarnow, Cho, and Wallace (2000) also recommended a need for at least 1.5 mm of distance between an implant and the adjacent root, and at least 3 mm of distance between two adjacent implants, to accommodate ideal interproximal bone levels as well as for papilla support.
Several techniques have been proposed and widely used to augment deficient ridges. Guided bone regeneration (GBR) is one of the most utilized techniques, and it consists of using grafting materials in combination with a barrier, either a nonresorbable membrane (Buser, Bragger, Lang, & Nyman, 1990) or an absorbable membrane (Mellonig & Nevins, 1995) . Other techniques include the use of a bone block graft (Misch, 1997) or a ridge-split technique (Simion, Baldoni, & Zaffe, 1992) . Additionally, the use of distraction osteogenesis to augment the edentulous ridge has also been proposed (Chiapasco, Romeo, & Vogel, 2001; Chin, 1999) . Recently, the "sandwich" technique has been described to regenerate horizontal and vertical bone defects at peri-implant sites (Wang, Misch, & Neiva, 2004) . All these techniques are effective; however, complications can occur during the healing phase of treatment, creating undesired outcomes.
Successful GBR procedures are dependent on four fundamental principles that must ensue during the surgery and throughout healing. These principles consist of primary closure, angiogenesis, space maintenance, and stability of the wound, the so-called PASS principle (Wang & Boyapati, 2006) . Complications with any of these principles can result in premature membrane exposure that potentially compromises the regenerative process. To minimize the risk of complications, clinicians should assess the amount of keratinized mucosa, tissue biotype, vestibular depth, flap flexibility, bone defect type and size, and type of membrane used (Chao, Chang, Fu, Wang, & Chan, 2015) . Each one of these factors has been identified as a contributing factor in membrane exposure.
As there is a need to understand the influence of membrane exposure on GBR outcomes, the goal of this study was to compare the amount of bone gain after GBR procedures between sites with and without membrane exposure. The primary outcome was the percentage of horizontal bone gain at edentulous ridges. The secondary outcome was the percentage of peri-implant bone dehiscence reduction at peri-implant sites.
| MATERIAL AND METHODS

| Focused question
What is the effect of membrane exposure on bone augmentation outcomes after horizontal ridge augmentation at edentulous sites after GBR procedures or at peri-implant sites immediately after implant placement?
| PICO question (problem, intervention, comparison, outcome)
P: Maxillary or mandibular partially edentulous healthy subjects who were to receive or had received dental implants to restore oral function I: GBR for horizontal ridge augmentation to augment bone width for future implant placement or to restore peri-implant dehiscence defects immediately after implant placement C: GBR outcomes between sites with and without membrane exposure O:
• Primary outcome: percentage of horizontal bone gain at sites with and without membrane exposure at edentulous ridges • Secondary outcome: percentage of peri-implant bone dehiscence reduction at sites with and without membrane exposure at peri-implant sites
| Information sources
Electronic and manual literature searches were conducted by two independent reviewers (JG and AD) in four databases, including MEDLINE, EMBASE, Web of Science, and Cochrane Central Register of Controlled Trials, for articles up to February 2017. Two reviewers independently extracted the data from studies (JG and AD). Publications that did not meet the inclusion criteria were excluded. In case of disagreements, consensus was reached by discussion with a third reviewer (GL). For the other databases, the key terms used for the search included GBR, alveolar ridge augmentation, dental implants, complication, and exposure.
| Screening process and data extraction
The screening in such databases was limited to "clinical studies" AND "humans" in all of the screening strategies. In addition, an electronic screening of the grey literature at the New York Academy of Medicine Grey Literature Report (http://greylit.org) and Google Scholar was conducted as recommended by high standards for systematic reviews, that is Assessment of Multiple Systematic Reviews (AMSTAR) guidelines (Shea et al., 2007 
| Data analyses
The primary outcome was the percentage of horizontal bone gain at edentulous sites in groups with and without membrane exposure. The 
| Risk of bias assessment
The criteria used to assess the quality of the selected randomized control trials (RCTs) were modified from the checklist of the Cochrane Center (Higgins & Green, 2011) . For non-RCTs, the Methodological Index for Non-Randomized Studies (MINORS) was used to rank the risk of bias of the included studies (Slim et al., 2003) . The degree of bias was categorized as follows: low risk if all the criteria were met, moderate risk when only one criterion was missing, and high risk if two or more criteria were missing.
Two reviewers (JG and GL) assessed all the included articles independently.
| RESULTS
| Data extraction
A total of 837 records were identified through the electronic and manual search process after exclusion of duplicates (Figure 1 ). Of these, 795 were screened based on the title and/or abstract content, and 42
were selected for full-text assessment and inclusion in the qualitative F I G U R E 1 PRISMA flowchart demonstrates the inclusion studies selection process Sethi & Kaus, 2001; Torres et al., 2010; Uehara et al., 2015; Urban, Nagursky & Lozada, 2011; Urban, Nagursky, Lozada, & Nagy, 2013; Wessing, Emmerich, & Bozkurt, 2016; Zitzmann, Naef, & Scharer, 1997) were excluded from the quantitative analysis due to lack of data, and eight studies (Annibali, Bignozzi, Sammartino, La Monaca, & Cristalli, 2012; Buser et al., 1990; Chiapasco, Abati, Romeo, & Vogel, 1999; Fu, Oh, Benavides, Rudek, & Wang, 2014; Gher, Quintero, Assad, Monaco, & Richardson, 1994; Nowzari & Slots, 1995; Park et al., 2008; Tawil, El-Ghoule, & Mawla, 2001 ) that reported on the primary and secondary outcomes were meta-analyzed. The kappa value between the two reviewers was 0.92 for titles and abstract evaluation, and 0.88 for full-text evaluation. The reasons for exclusion of specific studies are noted in Table S1 , and the main features of the included studies are summarized in Table 1 .
| Features of the included studies
| Study design and patient features
Three RCTs (Fu et al., 2014; Gher et al., 1994; Park et al., 2008) , four prospective case series (PCS; Buser et al., 1990; Chiapasco et al., 1999; Nowzari & Slots, 1995; Tawil et al., 2001) , and one retrospective case series (RCS; Annibali et al., 2012) were included in this study. The age range of the patients in the selected studies was 17-85 years. All the studies indicated the participants were systemically healthy, and only six studies (Annibali et al., 2012; Chiapasco et al., 1999; Fu et al., 2014; Gher et al., 1994; Nowzari & Slots, 1995; Park et al., 2008) pro- all patients who were smokers, pregnant, or had unstable periodontal diseases, or a history of drug or alcohol abuse; Gher et al. (1994) excluded pregnant patients; and Nowzari and Slots (1995) excluded patients who had antibiotic therapy within 6 months of the study period.
Two studies (Annibali et al., 2012; Chiapasco et al., 1999) included patients who were light smokers (<10 cigarettes per day).
The initial bone dimensions were provided by most of the studies, except for three (Fu et al., 2014; Gher et al., 1994; Park et al., 2008) .
The follow-up period after the GBR procedures, ranging from 4 to 14 months, was reported by all the included studies. Among the included articles, all studies reported no conflict of interest, except one study (Park et al., 2008) , which reported a conflict of interest with two private corporations.
| Types of membranes used
All the included studies used barrier membranes for GBR procedures.
Only two studies (Buser et al., 1990; Chiapasco et al., 1999 ) that measured horizontal bone gain at edentulous ridges utilized expanded polytetrafluoroethylene (e-PTFE) membranes. Of the studies analyzing the reduction in bone dehiscences at peri-implant sites, two studies (Gher et al., 1994; Nowzari & Slots, 1995) exclusively used e-PTFE membranes. One study (Annibali et al., 2012) used either titaniumreinforced e-PTFE or absorbable membranes; however, all membrane exposures occurred at sites with e-PTFE barriers. The other three studies (Fu et al., 2014; Park et al., 2008; Tawil et al., 2001) 
| Types of bone grafting materials used
All included studies, except for one (Nowzari & Slots, 1995) , reported the grafting materials used for the GBR procedures. For studies that measured horizontal bone gain at edentulous sites, one (Chiapasco et al., 1999) used autogenous bone grafts and the other (Buser et al., 1990 ) did not use bone grafting material at all. In terms of studies that analyzed dehiscence reduction at peri-implant sites, one study (Tawil et al., 2001 ) solely used autogenous cortical bone, another study (Gher et al., 1994) used demineralized freeze-dried bone allograft (DFDBA), two other studies (Fu et al., 2014; Park et al., 2008) used mineralized allograft, and the other one study (Annibali et al., 2012 ) used a combination of autogenous bone chips and DFDBA or bovine xenograft.
| Incidence of membrane exposure
For all studies, the exposure of the membrane was clinically detected during the follow-up period. The exposure resulted in surgical removal of the membrane in all but four studies (Fu et al., 2014; Gher et al., 1994; Park et al., 2008; Tawil et al., 2001) . Gher et al. (1994) had three patients with partial cover screw exposure at 2 weeks, yet the surgical site closed completely at the 1-month re-evaluation. The remaining studies reported membrane exposures from 8 to 10 days to 36 weeks postoperatively. Of these, the adverse events of the exposure were reported in two studies: Buser et al. (1990) reported unusual edema, and Nowzari and Slots (1995) reported inflammation, suppuration, and pain. The other two studies (Annibali et al., 2012; Chiapasco et al., 1999) did not comment on the events of the membrane exposure.
| Meta-analysis of the primary outcome & secondary outcome
As the size of the initial bone defect impacts the amount of defect reduction, only studies reporting the percentage of bone defect reduction were pooled for comparable comparisons.
T A B L E 1 Characteristics of the included studies NA, not available/applicable; GBR, guided bone regeneration; RCT, randomized controlled trial; PCS: prospective case series; RCS, retrospective case series; Auto, autogenous bone graft; Allo, allograft; Xeno: xenograft; Combo, combination grafts; N, nonresorbable membrane; R, absorbable membrane.
Two studies (Buser et al., 1990; Chiapasco et al., 1999) However, this subgroup analysis also revealed a high level of heterogeneity between the two studies (p value for chi-square test <.0007 and I 2 test = 91%). For the absorbable membrane subgroup, three studies (Fu et al., 2014; Park et al., 2008; Tawil et al., 2001) 
| Risk of bias assessment
The results of the risk of bias assessment for included case series are summarized in Table 2 (RCT) and Table 3 (non-RCTs). One RCT (Gher et al., 1994) and one case series (Annibali et al., 2012) were considered to have a high risk of bias. Another RCT (Fu et al., 2014) and four case series (Buser et al., 1990; Chiapasco et al., 1999; Nowzari & Slots, 1995; Tawil et al., 2001 ) were considered to have a moderate risk of bias. One other RCT was considered to have a low risk of bias (Park et al., 2008) . The kappa value of the interexaminer agreement for risk of bias assessment was 1.00. gain measured between the groups could yield incomparable datasets. For example, one of the included studies (Annibali et al., 2012) reported an average of 5.00 mm of bone gain for sites with membrane exposure, which is greater than the 3.19 mm gained at sites without membrane exposure. While this seems to suggest almost 2 mm of difference between the groups, when analyzed by the percentage of defect reduction, the two groups showed comparable percentages of defect reduction, 90.82% for sites without membrane exposure, and 87.50% for sites with exposure, respectively. In order to compare the outcomes more meaningfully and to avoid potentially biased analyses, we used the percentage of horizontal bone gain/dehiscence reduction instead of linear measurements as our study outcomes.
| DISCUSSION
The objective of using a barrier membrane is to prevent the ingrowth of soft tissue, while providing space for the graft and allowing oxygen and nutrients to enter the grafted site (Rakhmatia, Ayukawa, Furuhashi, & Koyano, 2013) . Prior to our study, no meta-analysis has been performed to compare the resulting bone gain of edentulous sites under exposed and nonexposed GBR membranes. We found that the sites without membrane exposure achieved 74% more horizontal bone gain than those with exposure. However, it is worth mentioning that the two articles (Annibali et al., 2012; Nowzari & Slots, 1995) exclusively used e-PTFE barriers instead of dense PTFE (d-PTFE) barriers. The difference in bacterial resistance between e-PTFE and d-PTFE (d-PTFE being more resistant) could be significant.
F I G U R E 2 Forest plots representing the outcomes of the percentage of horizontal bone width gain after GBR at edentulous ridges between groups with and without membrane exposure. Meta-analysis showed a statistically significant difference (WMD = −76.24%, with a 95% CI of −137.52% to −14.97%, p = .01), favoring the group without membrane exposure Studies have shown that intentionally exposed d-PTFE membranes for socket preservation procedures (Greenstein & Carpentieri, 2015) as well as GBR procedures (Hoffmann et al., 2008; Waasdorp & Feldman, 2013) did not exhibit significantly compromised regenera- Once compromised, the soft tissue begins to infiltrate the membrane, resulting in a much more difficult removal of the membrane and less favorable outcomes (Rakhmatia et al., 2013) .
Regarding GBR at peri-implant dehiscence sites, our study analyzed five articles (Annibali et al., 2012; Fu et al., 2014; Nowzari & Slots, 1995; Park et al., 2008; Tawil et al., 2001 ) that included 87 surgical sites, and found 27% more defect reduction at sites without membrane exposure compared to those with exposures. This difference, however, is even more critical when considering absorbable (Fu et al., 2014; Park et al., 2008; Tawil et al., 2001) vs. nonresorbable membranes. As absorbable membranes are primarily metabolized through enzymatic degradation, once they become exposed, these membranes have a greater susceptibility to infection and a faster degradation rate.
Membrane exposures compromise space maintenance and cell exclusion properties, leading to detrimental effects that are readily seen in subsequent outcomes. It has been reported that bacterial invasion of the exposed absorbable membrane could occur as early as 3 weeks (Simion et al., 1997) . During the first week of exposure, the outer surface of the barrier is colonized by bacteria, and by week three to four, the bacteria have invaded the entire thickness of the membrane.
Bacterial invasion results in membrane resorption and creation of irregular voids in the barrier, which degrade the functional integrity of the barrier. Even with the long-lasting cross-linked collagen barriers, Tal, Kozlovsky, Artzi, Nemcovsky, and Moses (2008) found that bone regeneration outcomes were compromised once membranes were exposed.
Interestingly, one study (Park et al., 2008) found a significant difference in peri-implant dehiscence defect reduction between sites with and without barrier exposure in a collagen membrane group but not in an ADM group. Four of six sites with ADM exposure were epithelialized after a 1-month period. The authors attributed this favorable outcome to the polarized matrix nature of ADM, which consisted of a basal lamina for epithelial cell migration and an underlying porous dermal matrix for angiogenic cell ingrowth (Cummings, Kaldahl, & Allen, 2005) . However, although the difference was not statistically significant, it is worth noting that 25% less dehiscence defect reduction was still detected in the exposed ADM group than the nonexposed group. Our study findings are consistent with several previously published human studies reporting on membrane exposure, which show early membrane removal and compromised bone regeneration (von Arx, Hardt, & Wallkamm, 1996; Proussaefs & Lozada, 2006) . It has been demonstrated that the timely membrane removal within 4 weeks of membrane exposure could still potentially result in successful bone augmentation (Annibali et al., 2012; Proussaefs & Lozada, 2006) .
Annibali et al. (2012) treated patients with systemic antibiotic therapy
(1 g amoxicillin-clavulanate, twice a day for 6 days) when membrane exposure occurred. The membrane was subsequently removed after reentry surgery, and the flap was closed. The graft was allowed to heal for an additional period ranging from 3 to 8 months. The study outcome showed a comparable amount of defect reduction between sites with and without membrane exposure. Therefore, proper management of membrane exposure could minimize the negative outcomes.
Both peri-implant and edentulous sites exhibit a significant decrease in regeneration outcomes if membranes become exposed.
Therefore, it can be concluded that healing with primary intention is a crucial factor for GBR procedures. Chao et al. (2015) reported the soft tissue quality, flap flexibility, as well as the types of barrier membranes used have an important impact on wound opening. Ideally, an adequate amount of keratinized tissue, a thick tissue biotype, a deep vestibular depth, and high flap flexibility with a use of absorbable membranes might minimize the incidence of wound opening. The authors also reported that the use of nonresorbable membranes potentially has higher risk of membrane exposure compared to absorbable ones due to a tendency to revert to their original shape after being molded. However, our search did not identify clinical data on d-PTFE or absorbable synthetic membranes; thus, the influence of exposure of these types of barriers after GBR procedures on clinical outcomes cannot be determined at this time.
Other than membrane exposure, another important factor to be considered is that of soft tissue dehiscence at surgical sites. Two included studies (Fu et al., 2014; Park et al., 2008) had a control group for grafting materials alone without utilizing a barrier membrane. The authors attributed this outcome to the use of the "sandwich bone augmentation" technique. Previous studies (Lorenzoni, Pertl, Keil, & Wegscheider, 1998; Lorenzoni et al., 2002) have confirmed that an absence of soft tissue dehiscence caused significant gain in the quantity of bone augmentation. Therefore, it can be concluded that both wound dehiscence and membrane exposure are contributing factors T A B L E 3 Risk of bias assessment for the included case series using the Methodological Index for Non-Randomized Studies (MINORS)
to unfavorable grafting outcomes. Clinically, achieving tension-free primary closure and wound stability to minimize the chance of wound dehiscence and membrane exposure is important (Lim, Lin, Monje, Chan, & Wang, 2017) .
There are several limitations in the current study. First, only eight papers were included in the current study. Second, most analyses were presented with high heterogeneity due to the different study designs, follow-up periods, materials used, etc. Third, all the included studies were deemed to have moderate to high risk of bias. This could be explained by the difficulty of conducting prospective studies to analyze outcomes on membrane exposure as this type of adverse event is hard to predict. Fourth, patient-centered outcomes were not analyzed in the current review due to the limited data. Fifth, our study only identified data on e-PTFE and collagen membranes. Future studies investigating the impact of membrane exposure with other types of currently available barriers, that is d-PTFE, on clinical parameters are needed.
| CONCLUSION
Based on the findings of the current study, membrane exposure after GBR procedures has a significant detrimental influence on the amount of bone augmentation. For GBR at edentulous sites, sites without membrane exposure achieved 74% more horizontal bone gain than sites with exposure. For peri-implant dehiscence defects, the sites without membrane exposure had 27% more defect reduction than sites with exposure. However, these outcomes are associated with collagen membranes and e-PTFE barriers. Future studies investigating the impact of membrane exposure with other types of currently available barriers on clinical parameters are needed.
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